Ruben de Jong studied biological and medical laboratorial research in Groningen, medical biology in Amsterdam and obtained his master degree in policy analysis, management and entrepreneurship in 2005. Between 2004 and 2011 Ruben held a number of project management positions at Xendo Drug Development BV and later QPS Netherlands BV, a phase 1 CRO. In these roles he was responsible for a portfolio of >25 phase 1/2a studies per year. From 2011 to 2018 Ruben was appointed as Director Project Management and a member of the management team at this CRO. Since January 2018, Ruben has been the Head of Research for the UMCG department of Cardiology and COO of G-Cure BV, where he is responsible for the operational aspects of (pre-)clinical research conducted by the department of Cardiology.
